The molecular interactions of oncogenes are complex because they impinge upon elaborate pathways that regulate cellular proliferation and differentiation. In the case of the ski oncogene, this is illustrated by the finding that retroviral mediated overexpression of either v-ski or the proto-oncogene, c-ski, transforms avian embryo fibroblasts and converts them into skeletal myoblasts. V-Ski and c-Ski apparently accomplish these biological feats by binding DNA on their own and in combination with other proteins, and activating transcription via their DNA binding sites. The overall goal of this work is to determine which molecular interactions and activities of ski are responsible for its ability to induce oncogenic transformation. In several of the proposed studies v-ski mutants that are defective in their transforming and myogenic activity will be used to determine which of the biochemical functions of Ski are essential for its biological activity. One of the molecular interactions to be probed is that of Ski and the members of the NF-1 family of transcription/replication factors. Ski activates transcription in combination with some NF-i proteins but not others, and these studies will examine both Ski's role as a co-regulator of NF-i action, and the roles of individual NF-1 forms in the cell-specific action of Ski. Another interaction to be studied is that between ski and the closely related gene, sno. Retroviral overexpression of snoN also leads to transformation of fibroblasts and the present studies will determine whether Ski and Sno function together as transcriptional activators or repressors. Two v-ski mutants which act as dominant negative repressors of both v-ski-induced transformation and c-ski function in normal cellular proliferation and differentiation will serve to probe the role of ski in these processes by examining the nature of the cell cycle block imposed by their action. The ubiquitous expression of c-ski and its pleiotropic effects suggest that Ski must interact with an even more diverse set of partners than those identified above. Additional partners and downstream effectors of Ski function will be sought using DNA binding site selection and differential display of induced and repressed mRNA sequences.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA043600-10A1
Application #
2091208
Study Section
Experimental Virology Study Section (EVR)
Project Start
1986-03-01
Project End
1999-04-30
Budget Start
1995-07-01
Budget End
1996-04-30
Support Year
10
Fiscal Year
1995
Total Cost
Indirect Cost
Name
Case Western Reserve University
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
077758407
City
Cleveland
State
OH
Country
United States
Zip Code
44106
Zhang, Hong; Stavnezer, Ed (2009) Ski regulates muscle terminal differentiation by transcriptional activation of Myog in a complex with Six1 and Eya3. J Biol Chem 284:2867-79
Atanasoski, Suzana; Notterpek, Lucia; Lee, Hye-Youn et al. (2004) The protooncogene Ski controls Schwann cell proliferation and myelination. Neuron 43:499-511
Johnson, Michael; Morris, Shannon; Chen, Aiping et al. (2004) Selection of functional mutations in the U5-IR stem and loop regions of the Rous sarcoma virus genome. BMC Biol 2:8
Chen, Dahu; Xu, Weidong; Bales, Elise et al. (2003) SKI activates Wnt/beta-catenin signaling in human melanoma. Cancer Res 63:6626-34
Morris, Shannon; Johnson, Michael; Stavnezer, Ed et al. (2002) Replication of avian sarcoma virus in vivo requires an interaction between the viral RNA and the TpsiC loop of the tRNA(Trp) primer. J Virol 76:7571-7
Xu, W; Angelis, K; Danielpour, D et al. (2000) Ski acts as a co-repressor with Smad2 and Smad3 to regulate the response to type beta transforming growth factor. Proc Natl Acad Sci U S A 97:5924-9
Nicol, R; Zheng, G; Sutrave, P et al. (1999) Association of specific DNA binding and transcriptional repression with the transforming and myogenic activities of c-Ski. Cell Growth Differ 10:243-54
Cohen, S B; Zheng, G; Heyman, H C et al. (1999) Heterodimers of the SnoN and Ski oncoproteins form preferentially over homodimers and are more potent transforming agents. Nucleic Acids Res 27:1006-14
Nicol, R; Stavnezer, E (1998) Transcriptional repression by v-Ski and c-Ski mediated by a specific DNA binding site. J Biol Chem 273:3588-97
Cohen, S B; Nicol, R; Stavnezer, E (1998) A domain necessary for the transforming activity of SnoN is required for specific DNA binding, transcriptional repression and interaction with TAF(II)110. Oncogene 17:2505-13

Showing the most recent 10 out of 22 publications